Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 3,025,450 | 3,508,694 | +483,244 | $34.91M | $41.51M | 8.55% | +$6.59M |
| Protagonist Therapeutics Inc | 981,295 | 1,020,333 | +39,038 | $44.16M | $39.38M | 8.12% | -$4.77M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 323,382 | 325,450 | +2,068 | $35.23M | $35.89M | 7.40% | +$664.6K |
| Zai Lab LimitedADR(ZLAB) | 532,454 | 1,045,837 | +513,383 | $12.85M | $27.39M | 5.65% | +$14.54M |
| Immunovant, Inc.(IMVT) | 1,131,707 | 787,478 | -344,229 | $32.26M | $19.51M | 4.02% | -$12.76M |
| Cytokinetics, Incorporated(CYTK) | 911,182 | 414,209 | -496,973 | $48.11M | $19.48M | 4.02% | -$28.63M |
| BridgeBio Pharma, Inc.(BBIO) | 1,448,470 | 678,857 | -769,613 | $36.88M | $18.63M | 3.84% | -$18.25M |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 5,103,005 | +5,103,005 | $0 | $16.58M | 3.42% | +$16.58M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 21,786 | 131,786 | +110,000 | $2.00M | $12.05M | 2.48% | +$10.05M |
| ABIVAX Société AnonymeADS(ABVX) | 521,612 | 1,513,393 | +991,781 | $6.01M | $11.08M | 2.28% | +$5.07M |
| Mineralys Therapeutics, Inc.(MLYS) | 729,401 | 841,541 | +112,140 | $8.83M | $10.36M | 2.14% | +$1.53M |
| Ascendis Pharma A/SADR(ASND) | 161,402 | 71,402 | -90,000 | $24.10M | $9.83M | 2.03% | -$14.27M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.51M | $7.63M | 1.57% | +$120.0K |
| Revolution Medicines, Inc.(RVMD) | 44,351 | 170,000 | +125,649 | $2.01M | $7.44M | 1.53% | +$5.42M |
| Rezolute, Inc.(RZLT) | 1,571,705 | 1,359,208 | -212,497 | $7.62M | $6.66M | 1.37% | -$962.6K |
| Endeavor Group Hldgs IncCL A | 122,807 | 210,729 | +87,922 | $3.51M | $6.59M | 1.36% | +$3.09M |
| CG Oncology, Inc.(CGON) | 143,104 | 215,750 | +72,646 | $5.40M | $6.19M | 1.28% | +$788.4K |
| Anteris Technologies Global Corp.(AVR) | 0 | 1,052,968 | +1,052,968 | $0 | $5.88M | 1.21% | +$5.88M |
| Aa Mission Acquisition CorpCL A | 1,010,199 | 560,199 | -450,000 | $10.12M | $5.66M | 1.17% | -$4.46M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $0 | $5.48M | 1.13% | +$5.48M |
| Xencor, Inc.(XNCR) | 342,262 | 234,607 | -107,655 | $6.88M | $5.39M | 1.11% | -$1.49M |
| Zura Bio LimitedCL A(ZURA) | 3,770,649 | 2,077,251 | -1,693,398 | $15.31M | $5.19M | 1.07% | -$10.12M |
| Arbutus Biopharma Corporation(ABUS) | 2,089,321 | 1,554,802 | -534,519 | $8.04M | $5.08M | 1.05% | -$2.96M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 0 | 500,000 | +500,000 | $0 | $5.07M | 1.04% | +$5.07M |
| Sarepta Therapeutics, Inc.(SRPT) | 7,100 | 40,002 | +32,902 | $886.7K | $4.86M | 1.00% | +$3.98M |
| SanofiADR(SNY) | 0 | 99,600 | +99,600 | $0 | $4.80M | 0.99% | +$4.80M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $0 | $4.36M | 0.90% | +$4.36M |
| Helix Acquisition Corp IiCL A | 404,138 | 404,138 | 0 | $4.22M | $4.24M | 0.87% | +$20.2K |
| 89bio Inc | 6,560 | 515,138 | +508,578 | $48.5K | $4.03M | 0.83% | +$3.98M |
| BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO) | 0 | 0 | 0 | $0 | $3.86M | 0.80% | +$3.86M |
| Merus N V | 153,286 | 81,460 | -71,826 | $7.66M | $3.43M | 0.71% | -$4.23M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 436,668 | 166,406 | -270,262 | $10.91M | $3.29M | 0.68% | -$7.62M |
| Aldeyra Therapeutics, Inc.(ALDX) | 302,212 | 647,960 | +345,748 | $1.63M | $3.23M | 0.67% | +$1.60M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 108,171 | 146,671 | +38,500 | $1.95M | $3.23M | 0.67% | +$1.28M |
| Savara Inc.(SVRA) | 742,634 | 988,468 | +245,834 | $3.15M | $3.03M | 0.63% | -$114.2K |
| Grace Therapeutics, Inc.(GRCE) | 959,571 | 773,635 | -185,936 | $2.88M | $2.89M | 0.60% | +$14.7K |
| Monopar Therapeutics Inc.(MNPR) | 0 | 130,037 | +130,037 | $0 | $2.86M | 0.59% | +$2.86M |
| Crinetics Pharmaceuticals In | 88,425 | 53,125 | -35,300 | $4.52M | $2.72M | 0.56% | -$1.80M |
| Tectonic Therapeutic, Inc.(TECX) | 127,159 | 58,708 | -68,451 | $3.85M | $2.71M | 0.56% | -$1.14M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 4,300 | 211,400 | +207,100 | $79.4K | $2.66M | 0.55% | +$2.58M |
| Centessa Pharmaceuticals PlcADS | 23,302 | 154,027 | +130,725 | $372.6K | $2.58M | 0.53% | +$2.21M |
| Aerovate Therapeutics Inc | 113,075 | 928,016 | +814,941 | $236.3K | $2.46M | 0.51% | +$2.22M |
| Korro Bio, Inc.(KRRO) | 49,451 | 57,978 | +8,527 | $1.65M | $2.21M | 0.45% | +$554.6K |
| PTC Therapeutics, Inc.(PTCT) | 20,000 | 48,023 | +28,023 | $742.0K | $2.17M | 0.45% | +$1.43M |
| A Spac Iii Acquisition CorpUNIT 02 15 2029 UNIT 02/15/2029 | 0 | 215,000 | +215,000 | $0 | $2.17M | 0.45% | +$2.17M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $0 | $2.10M | 0.43% | +$2.10M |
| Xenon Pharmaceuticals Inc.(XENE) | 27,903 | 50,547 | +22,644 | $1.10M | $1.98M | 0.41% | +$882.9K |
| Apogee Therapeutics Inc | 57,183 | 41,274 | -15,909 | $3.36M | $1.87M | 0.39% | -$1.49M |
| Rapt Therapeutics Inc | 7,500 | 1,174,313 | +1,166,813 | $15.1K | $1.86M | 0.38% | +$1.84M |
| Delcath Systems, Inc.(DCTH) | 31,052 | 149,385 | +118,333 | $280.4K | $1.80M | 0.37% | +$1.52M |
| Pliant Therapeutics, Inc.(PLRX) | 246,128 | 134,798 | -111,330 | $2.76M | $1.78M | 0.37% | -$983.8K |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 144,641 | +144,641 | $0 | $1.74M | 0.36% | +$1.74M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 30,941 | +30,941 | $0 | $1.73M | 0.36% | +$1.73M |
| Janux Therapeutics, Inc.(JANX) | 13,000 | 31,509 | +18,509 | $590.6K | $1.69M | 0.35% | +$1.10M |
| Axsome Therapeutics, Inc.(AXSM) | 600 | 19,661 | +19,061 | $53.9K | $1.66M | 0.34% | +$1.61M |
| Soleno Therapeutics Inc | 10,000 | 36,830 | +26,830 | $504.9K | $1.66M | 0.34% | +$1.15M |
| KALA BIO, Inc.(KALA) | 306,067 | 220,373 | -85,694 | $1.74M | $1.53M | 0.32% | -$215.2K |
| Ares Acquisition Corp IiCL A | 138,966 | 138,966 | 0 | $1.51M | $1.53M | 0.31% | +$20.8K |
| Insmed Incorporated(INSM) | 3,634 | 21,974 | +18,340 | $265.3K | $1.52M | 0.31% | +$1.25M |
| Avid Bioservices Inc | 0 | 120,000 | +120,000 | $0 | $1.48M | 0.31% | +$1.48M |
| Acelyrin Inc | 53,500 | 444,967 | +391,467 | $263.8K | $1.40M | 0.29% | +$1.13M |
| Verona Pharma PlcADS | 10,000 | 29,100 | +19,100 | $287.7K | $1.35M | 0.28% | +$1.06M |
| REGENXBIO Inc.(RGNX) | 569,008 | 170,129 | -398,879 | $5.97M | $1.32M | 0.27% | -$4.65M |
| Poseida Therapeutics Inc | 0 | 134,109 | +134,109 | $0 | $1.29M | 0.27% | +$1.29M |
| Royalty Pharma plcCL A(RPRX) | 1,096,666 | 49,963 | -1,046,703 | $31.02M | $1.27M | 0.26% | -$29.75M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 8,967 | 82,234 | +73,267 | $171.6K | $1.20M | 0.25% | +$1.03M |
| Alpha Cognition Inc. Common Stock(ACOG) | 0 | 204,348 | +204,348 | $0 | $1.20M | 0.25% | +$1.20M |
| Geron Corporation(GERN) | 557,159 | 337,676 | -219,483 | $2.53M | $1.20M | 0.25% | -$1.33M |
| Lexeo Therapeutics, Inc.(LXEO) | 57,166 | 169,505 | +112,339 | $516.8K | $1.12M | 0.23% | +$598.6K |
| Eli Lilly and Company(LLY) | 1,150 | 1,350 | +200 | $1.02M | $1.04M | 0.21% | +$23.4K |
| iBio, Inc.CON NEW(IBIO) | 476,212 | 415,606 | -60,606 | $1.06M | $1.02M | 0.21% | -$39.0K |
| Iteos Therapeutics Inc | 376,737 | 131,599 | -245,138 | $3.85M | $1.01M | 0.21% | -$2.84M |
| Kezar Life Sciences Inc COM NEW | 1,338,273 | 147,404 | -1,190,869 | $1.03M | $990.6K | 0.20% | -$44.2K |
| OmniAb, Inc.(OABI) | 1,337,302 | 278,108 | -1,059,194 | $5.66M | $984.5K | 0.20% | -$4.67M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 871 | 1,361 | +490 | $915.6K | $969.5K | 0.20% | +$53.9K |
| Structure Therapeutics IncADS | 0 | 35,319 | +35,319 | $0 | $957.9K | 0.20% | +$957.9K |
| Beam Therapeutics Inc.(BEAM) | 43,900 | 38,312 | -5,588 | $1.08M | $950.1K | 0.20% | -$125.4K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 23,457 | 17,424 | -6,033 | $1.18M | $943.5K | 0.19% | -$239.2K |
| Pfizer Inc.(PFE) | 35,950 | 35,050 | -900 | $1.04M | $929.9K | 0.19% | -$110.5K |
| Fulcrum Therapeutics, Inc.(FULC) | 55,802 | 196,248 | +140,446 | $199.2K | $922.4K | 0.19% | +$723.2K |
| Danaher Corporation(DHR) | 0 | 4,000 | +4,000 | $0 | $918.2K | 0.19% | +$918.2K |
| Denali Therapeutics Inc.(DNLI) | 101,826 | 44,826 | -57,000 | $2.97M | $913.6K | 0.19% | -$2.05M |
| Scholar Rock Holding Corporation(SRRK) | 12,000 | 19,505 | +7,505 | $96.1K | $843.0K | 0.17% | +$746.9K |
| Agriculture & Nat Sol Acq CoCL A SHS CL A | 80,362 | 80,362 | 0 | $831.7K | $843.0K | 0.17% | +$11.3K |
| Spero Therapeutics, Inc.(SPRO) | 743,459 | 801,277 | +57,818 | $996.2K | $825.3K | 0.17% | -$170.9K |
| Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF) | 75,000 | 75,000 | 0 | $804.8K | $824.3K | 0.17% | +$19.5K |
| Astria Therapeutics Inc | 93,284 | 90,984 | -2,300 | $1.03M | $813.4K | 0.17% | -$213.7K |
| Capricor Therapeutics, Inc.(CAPR) | 24,307 | 56,120 | +31,813 | $369.7K | $774.5K | 0.16% | +$404.7K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 68,608 | +68,608 | $0 | $727.2K | 0.15% | +$727.2K |
| Voyager Therapeutics, Inc.(VYGR) | 40,634 | 126,792 | +86,158 | $237.7K | $718.9K | 0.15% | +$481.2K |
| BioAge Labs, Inc.(BIOA) | 0 | 123,037 | +123,037 | $0 | $712.4K | 0.15% | +$712.4K |
| Alector Inc | 428,802 | 368,330 | -60,472 | $2.00M | $696.1K | 0.14% | -$1.30M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 2,900 | +2,900 | $0 | $682.4K | 0.14% | +$682.4K |
| Indivior Plc | 54,057 | 54,057 | 0 | $527.1K | $671.9K | 0.14% | +$144.9K |
| Day One Biopharmaceuticals I COM | 53,111 | 53,023 | -88 | $739.8K | $671.8K | 0.14% | -$68.0K |
| Cidara Therapeutics Inc | 0 | 24,938 | +24,938 | $0 | $670.3K | 0.14% | +$670.3K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 196,551 | 200,221 | +3,670 | $719.4K | $660.7K | 0.14% | -$58.6K |
| Protara Therapeutics, Inc.(TARA) | 0 | 122,690 | +122,690 | $0 | $647.8K | 0.13% | +$647.8K |
| Instil Bio, Inc.(TIL) | 23,707 | 31,708 | +8,001 | $1.60M | $605.3K | 0.12% | -$990.6K |
| Organon & Co.(OGN) | 3,100 | 40,200 | +37,100 | $59.3K | $599.8K | 0.12% | +$540.5K |